Cleared Special

K211199 - ST AIA-PACK BNP Assay (FDA 510(k) Clearance)

Nov 2021
Decision
200d
Days
Class 2
Risk

K211199 is an FDA 510(k) clearance for the ST AIA-PACK BNP Assay. This device is classified as a Test, Natriuretic Peptide (Class II - Special Controls, product code NBC).

Submitted by Tosoh Bioscience, Inc. (South San Franciso, US). The FDA issued a Cleared decision on November 8, 2021, 200 days after receiving the submission on April 22, 2021.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1117.

Submission Details

510(k) Number K211199 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2021
Decision Date November 08, 2021
Days to Decision 200 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code NBC — Test, Natriuretic Peptide
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1117

Similar Devices — NBC Test, Natriuretic Peptide

All 7
Alere NT-proBNP for Alinity i
K253539 · Axis-Shield Diagnostics, Ltd. · Feb 2026
Alere NT-proBNP for Alinity i Reagent Kit
K241176 · Axis-Shield Diagnostics, Ltd. · Jan 2025
Access NT-proBNP
K232164 · Beckman Coulter, Inc. · Apr 2024
ADVIA Centaur® NT-proBNPII (PBNPII)
K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 2023
Elecsys proBNP II, Elecsys proBNP II STAT
K223637 · Roche Diagnostics · Jul 2023
Elecsys proBNP II, Elecsys proBNP II STAT
K210546 · Roche Diagnostics · Mar 2022